YAP1802 Antibody

Shipped with Ice Packs
In Stock

Description

Introduction to YAP1802 Antibody

YAP1802 antibody is a specialized immunological tool targeting Yap1802, the Saccharomyces cerevisiae ortholog of human phosphatidylinositol-binding clathrin assembly protein (PICALM). This protein plays critical roles in clathrin-mediated endocytosis (CME) and amyloid-β (Aβ) oligomerization regulation, with implications for neurodegenerative diseases like Alzheimer’s (AD) . The antibody enables detection and functional analysis of Yap1802 in yeast models, providing insights into conserved molecular mechanisms relevant to human pathology.

Mechanism of Action

Yap1802 regulates endocytosis through three interconnected mechanisms:

Lipid and Cargo Recruitment

  • Budding yeast strains with Yap1802 K21E/K23E mutations show 40% reduced plasma membrane localization due to impaired phospholipid binding .

  • L203S mutants exhibit defective Snc1/2 internalization, increasing Snc2 cortical signal by 2.5-fold in mother cells .

Clathrin Coordination

  • Deletion of both Yap1801/Yap1802 disrupts Snc1 polarization, mimicking clathrin-null phenotypes .

  • Overexpression increases clathrin-coated pit density by 30% under glucose starvation .

Aβ42 Oligomerization Inhibition

  • Yeast expressing Yap1802 show a 60% reduction in SDS-resistant Aβ42 oligomers and restored growth on -Ade media .

Key Research Findings

Study FocusMethodologyKey ResultSource
Aβ42 toxicity suppressionAβ42-RF fusion reporter assayYap1802 overexpression reduced oligomers by 60% (p < 0.01)
Snc1/2 trafficking defectsCRISPR-generated L203S mutantsSnc2 cortex signal increased 2.5× in mother cells (p < 0.001)
Glucose-regulated endocytosisMig1/Mig2 transcriptional control analysisRaffinose-induced Yap1802 upregulation accelerated endocytosis by 40%
AP180-clathrin redundancyyap1801Δ/yap1802Δ double mutantsSnc1 surface levels increased 3.8× compared to wild-type

Therapeutic Implications

  • AD Pathogenesis: Yap1802’s ability to suppress Aβ42 oligomerization aligns with PICALM’s identification as an AD risk gene .

  • Drug Discovery: Seven FDA-approved drugs (e.g., haloperidol, tamoxifen) mimic Yap1802’s anti-oligomerization effects in yeast .

  • Vesicle Trafficking: Restoring Yap1802 function rescues endocytic defects in C. elegans and mammalian neurons .

Future Directions

  1. Structural Analysis: Cryo-EM studies of Yap1802-Snc2 complexes to refine interaction interfaces .

  2. In Vivo Models: Testing YAP1802 antibody efficacy in murine AD models with humanized PICALM variants .

  3. Clinical Translation: Developing small-molecule agonists mimicking Yap1802’s ANTH domain for Aβ clearance .

Product Specs

Buffer
**Preservative:** 0.03% Proclin 300
**Constituents:** 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
YAP1802 antibody; YGR241C antibody; G8610 antibody; Clathrin coat assembly protein AP180B antibody
Target Names
YAP1802
Uniprot No.

Target Background

Function
YAP1802 Antibody plays a crucial role in endocytosis and clathrin cage assembly.
Database Links

KEGG: sce:YGR241C

STRING: 4932.YGR241C

Protein Families
AP180 family
Subcellular Location
Bud. Bud neck. Cell membrane; Peripheral membrane protein; Cytoplasmic side. Cytoplasm.

Q&A

What is YAP1802 and what cellular processes is it involved in?

YAP1802 is an endocytic adaptor protein found in Saccharomyces cerevisiae (baker's yeast) that functions as a homolog to mammalian AP180. It plays a key role in clathrin-mediated endocytosis (CME), particularly in the early stages of endocytic site initiation . YAP1802 and its paralog YAP1801 are critical factors that promote polarized CME, showing strong localization to the bud cortex during yeast cell growth while remaining nearly undetectable in mother cells . This explains the observed position-dependent differences in CME initiation rates and lifetimes .

YAP1802 works cooperatively with other proteins such as Syp1 (the yeast homolog of FCHo1/2) to recruit Ede1 (the yeast homolog of EPS15) to the bud cortex, thereby initiating the early stages of CME . Additionally, YAP1802 interacts with v-SNAREs Snc1 and Snc2 (abbreviated as Snc1/2), which depend on CME for their retrieval from the plasma membrane . These v-SNAREs are the only known ones in budding yeast that facilitate the fusion of secretory vesicles with the plasma membrane . YAP1802 also directly binds anionic lipid species, suggesting a multifaceted role in membrane trafficking and cellular polarity .

What are the structural features and functional domains of YAP1802?

YAP1802 contains an ANTH (AP180 N-terminal homology) domain that mediates its interactions with both anionic phospholipids and synaptobrevins (Snc1/2 in yeast) . Key residues within this domain include lysines 21 and 23, which are critical for lipid interaction, and leucine 203, which is important for Snc1/2 interaction .

Structural studies using Alphafold2 multimer analysis have confirmed the specific interaction between L203 in YAP1802 and M42 in Snc2, strengthening confidence in the molecular basis of this protein-protein interaction . The protein also contains NPF motifs that enable interaction with Ede1, which becomes particularly evident when both lipid and Snc1/2 binding are disrupted, as YAP1802 then shows elevated localization at the bud neck where Ede1 is concentrated .

Understanding these structural features is essential for researchers designing experiments involving YAP1802 mutations or studying its binding partners in the context of endocytosis and membrane trafficking.

What are the specifications of commercially available YAP1802 antibodies?

The commercially available YAP1802 antibodies have the following specifications:

ParameterSpecification
Product TypePolyclonal Antibody
Raised InRabbit
ClonalityPolyclonal
IsotypeIgG
ImmunogenRecombinant Saccharomyces cerevisiae (strain ATCC 204508 / S288c) YAP1802 protein
Species ReactivitySaccharomyces cerevisiae (strain ATCC 204508 / S288c)
Tested ApplicationsELISA, Western Blot
FormLiquid
Purification MethodAntigen Affinity Purified
Storage Buffer0.03% Proclin 300, 50% Glycerol, 0.01M PBS (pH 7.4)
Storage Conditions-20°C or -80°C, avoid repeated freeze-thaw cycles
Uniprot IDP53309
Lead Time14-16 weeks (made-to-order)

These antibodies are designed for research use only and not for diagnostic or therapeutic procedures .

What validated applications are available for YAP1802 antibody in yeast research?

YAP1802 antibodies have been validated primarily for Enzyme-Linked Immunosorbent Assay (ELISA) and Western Blotting (WB) for the detection and identification of YAP1802 in Saccharomyces cerevisiae samples . These applications allow researchers to confirm the presence and relative abundance of YAP1802 in experimental samples.

In research settings studying YAP1802 function, fluorescently tagged versions (such as YAP1802-GFP) have been instrumental in visualizing the subcellular localization and dynamics of YAP1802 during endocytosis . This approach has revealed the strongly polarized distribution of YAP1802 to daughter cells during yeast budding and has enabled the quantitative analysis of YAP1802 recruitment patterns and endocytic event lifetimes .

For interaction studies, YAP1802 antibodies could potentially be used in co-immunoprecipitation experiments to investigate protein-protein interactions between YAP1802 and its binding partners, such as Snc1/2, Syp1, or Ede1, though specific protocols for this application were not explicitly mentioned in the search results.

How should researchers design Western blot protocols using YAP1802 antibody?

When designing Western blot protocols using YAP1802 antibody, researchers should consider the following methodological approach:

  • Sample Preparation:

    • Extract proteins from yeast cells using appropriate lysis buffers containing protease inhibitors

    • Quantify protein concentration using Bradford or BCA assay

    • Prepare samples in SDS-PAGE loading buffer with reducing agent

  • Gel Electrophoresis and Transfer:

    • Separate proteins using SDS-PAGE with an appropriate percentage gel based on YAP1802's molecular weight

    • Transfer proteins to a PVDF or nitrocellulose membrane

  • Antibody Incubation:

    • Block membrane with 5% non-fat milk or BSA in TBST

    • Incubate with YAP1802 antibody at an optimized dilution (typically starting at 1:1000)

    • Wash thoroughly with TBST

    • Incubate with HRP-conjugated anti-rabbit secondary antibody

  • Detection and Controls:

    • Develop using enhanced chemiluminescence (ECL) reagents

    • Include wild-type yeast extracts as positive control

    • Include yap1802Δ deletion strain extracts as negative control

    • Use loading controls such as anti-Pgk1 or anti-Tub1 antibodies

  • Analysis of YAP1802 Mutations:

    • When analyzing YAP1802 mutants, include wild-type YAP1802 in the same blot for direct comparison

    • Verify expression levels of mutant and wild-type proteins to ensure differences observed are not due to expression variations

This methodological approach ensures specific and reliable detection of YAP1802 in yeast samples while controlling for potential sources of error.

What are the optimal storage and handling protocols for YAP1802 antibody?

For optimal performance and longevity of YAP1802 antibodies, researchers should follow these storage and handling protocols:

  • Initial Storage:

    • Store antibody at -20°C or -80°C immediately upon receipt

    • Avoid repeated freeze-thaw cycles that can denature the antibody

  • Working Solution Preparation:

    • Thaw antibody on ice slowly and completely

    • Aliquot stock solution into smaller volumes to minimize future freeze-thaw cycles

    • Return unused stock to -20°C or -80°C immediately

  • Buffer Compatibility:

    • The antibody is supplied in a storage buffer containing 50% glycerol, 0.01M PBS at pH 7.4, and 0.03% Proclin 300 as a preservative

    • When diluting, use buffers compatible with the intended application (TBST for Western blotting, PBS for ELISA)

  • Temperature Management:

    • Keep antibody cold (on ice or at 4°C) during experimental procedures

    • Avoid exposing the antibody to room temperature for extended periods

  • Contamination Prevention:

    • Use sterile technique when handling antibody solutions

    • Avoid introducing bacteria or fungi that could degrade the antibody

Following these protocols will help maintain antibody activity and specificity throughout its shelf life and during experimental use.

How do mutations in YAP1802 affect its localization and function in clathrin-mediated endocytosis?

Research has demonstrated that specific mutations in key binding domains of YAP1802 significantly impact its localization and function in clathrin-mediated endocytosis (CME) . The effects of different mutations have been systematically characterized:

MutationDomain AffectedEffect on LocalizationEffect on Function
K21E K23EANTH domain (lipid binding)Decreased plasma membrane recruitment in daughter cellsReduced cortical Yap1802 intensity, defects in Snc2 internalization
L203SANTH domain (Snc1/2 binding)Decreased plasma membrane recruitmentReduced cortical Yap1802 intensity, defects in Snc2 internalization
K21E K23E L203S (3x PM)Both lipid and Snc1/2 bindingSevere recruitment defect, abnormal concentration at bud neckSignificantly shorter lifetimes at endocytic sites, severe defects in Snc2 internalization

These mutations affect not only YAP1802 localization but also the dynamics of its cargo. In yeast expressing YAP1802 with these mutations, Snc2 shows abnormal distribution patterns on the plasma membrane, with increased cortical signal in mother cells across all mutant conditions . This suggests that the interaction between YAP1802 and both lipids and cargo (Snc1/2) is crucial for proper endocytic function.

The triple mutant (K21E K23E L203S) shows an unusual concentration at the bud neck, likely due to recruitment by Ede1 through YAP1802's NPF motifs, as Ede1 is concentrated at this location . The lifetimes of this triple mutant at endocytic sites are significantly shorter than those for the wild-type and individual mutants, consistent with strains that lack the ability to localize Ede1 properly .

These findings highlight the complex interplay between YAP1802's interactions with lipids, cargo proteins, and other endocytic factors in establishing the polarized endocytic machinery in budding yeast.

What is the relationship between YAP1802 and anionic phospholipids in polarized endocytosis?

YAP1802 exhibits a direct interaction with anionic phospholipid species through its ANTH domain, specifically via lysine residues 21 and 23 . This interaction is critical for the polarized recruitment of YAP1802 to the bud cortex during yeast cell growth. The relationship between YAP1802 and anionic phospholipids has several important aspects:

  • Lipid Specificity: YAP1802's ANTH domain can directly bind anionic lipid species, which likely contribute to its membrane association .

  • Polarized Distribution: Anionic lipids, particularly phosphatidylserine, are enriched in daughter cells, creating a lipid environment that favors YAP1802 recruitment . This lipid asymmetry may contribute to the observed polarization of endocytic processes.

  • Functional Significance: When the interaction between YAP1802 and anionic phospholipids is disrupted through K21E K23E mutations, YAP1802 shows significantly reduced plasma membrane association in daughter cells, as evidenced by decreased cortical fluorescence intensity .

  • Cargo Protein Effect: The defect in lipid binding not only affects YAP1802 localization but also leads to abnormal distribution of its cargo Snc2, with increased cortical signal in mother cells . This indicates that the lipid-binding function of YAP1802 is essential for proper cargo internalization.

  • Coordination with Protein Binding: While both lipid binding and Snc1/2 binding independently contribute to YAP1802 localization, the most severe defects are observed when both interactions are disrupted in the triple mutant (K21E K23E L203S) . This suggests that these interactions work cooperatively to ensure proper YAP1802 function.

These findings highlight the importance of membrane lipid composition in regulating the spatial organization of endocytic machinery and suggest that anionic phospholipids serve as spatial cues for the recruitment of early endocytic factors like YAP1802.

How does the interaction between YAP1802 and Snc1/2 influence vesicle trafficking and endocytosis?

The interaction between YAP1802 and the v-SNAREs Snc1/2 represents a critical nexus between exocytosis and endocytosis in yeast cells . This relationship has several important implications for vesicle trafficking:

  • Cargo Recognition: YAP1802 recognizes Snc1/2 as cargo for endocytosis through a specific interaction between leucine 203 in YAP1802's ANTH domain and methionine 42 in Snc2, as confirmed by Alphafold2 multimer analysis .

  • Endocytic Recycling: Snc1/2 are the only known v-SNAREs in budding yeast that facilitate the fusion of secretory vesicles with the plasma membrane . After fusion, they require clathrin-mediated endocytosis (CME) for their retrieval from the plasma membrane, a process mediated by YAP1802 .

  • Bidirectional Influence: The YAP1802-Snc1/2 interaction appears to be bidirectional: YAP1802 mediates Snc1/2 internalization, while Snc1/2 contributes to YAP1802 recruitment to endocytic sites. When this interaction is disrupted through the L203S mutation, YAP1802's plasma membrane recruitment is impaired .

  • Effect on Snc1/2 Distribution: In yeast expressing the YAP1802 L203S mutant (defective in Snc1/2 binding), Snc2 shows abnormal accumulation at the cell cortex, particularly in mother cells . This indicates that the YAP1802-Snc1/2 interaction is essential for efficient Snc2 internalization.

  • Coordination with Lipid Binding: While the interaction with Snc1/2 contributes to YAP1802 localization, it works cooperatively with lipid binding to ensure proper YAP1802 function. The most severe defects in both YAP1802 localization and Snc2 internalization are observed when both interactions are disrupted in the triple mutant (K21E K23E L203S) .

This complex relationship between YAP1802 and Snc1/2 illustrates how the secretory and endocytic pathways are coordinated in yeast cells, with endocytic adaptor proteins recognizing and internalizing components of the exocytic machinery to maintain proper membrane homeostasis.

What controls should be included when using YAP1802 antibody in immunoblotting experiments?

When conducting immunoblotting experiments with YAP1802 antibody, researchers should include the following controls to ensure result reliability and accuracy:

  • Positive Control: Include wild-type yeast extracts known to express YAP1802 . This confirms that the antibody and detection system are working properly.

  • Negative Control: Use extracts from yap1802Δ deletion strains, which should show no band at the expected molecular weight. This confirms the specificity of the antibody for YAP1802.

  • Antigen Competition Control: For antibody specificity validation, perform an antigen competition assay by pre-incubating the antibody with excess purified YAP1802 protein before immunoblotting. This should greatly reduce or eliminate specific binding.

  • Loading Controls: Use antibodies against constitutively expressed yeast proteins such as Pgk1 (phosphoglycerate kinase) or Tub1 (α-tubulin) to ensure equal loading across lanes, especially important for quantitative comparisons.

  • Mutation Comparison Controls: When studying YAP1802 mutants (such as K21E K23E or L203S), include wild-type YAP1802 samples in the same blot for direct comparison . This allows accurate assessment of how mutations affect protein expression or migration.

  • Tag Controls: If detecting tagged versions of YAP1802 (such as YAP1802-GFP), include controls with untagged YAP1802 to verify tag effects on protein migration or expression levels .

  • Secondary Antibody-Only Control: Include a lane where primary antibody is omitted to identify any non-specific binding of the secondary antibody.

  • Molecular Weight Marker: Use a pre-stained protein ladder for accurate molecular weight determination of detected bands.

These controls collectively ensure that the observed results are specific, reproducible, and reliably attributed to YAP1802 rather than experimental artifacts or cross-reactivity.

How can researchers interpret data contradictions in YAP1802 localization studies?

When encountering contradictory data in YAP1802 localization studies, researchers should systematically evaluate several potential sources of variation:

  • Strain Background Differences: Even minor genetic variations between laboratory yeast strains can affect protein localization patterns. Verify strain genotypes and consider backcrossing strains to a common background for direct comparisons.

  • Cell Cycle Dependence: YAP1802 localization is strongly influenced by cell cycle stage, given its polarized distribution to daughter cells during budding . Contradictions may arise if cell populations are at different cell cycle stages. Synchronize cultures or categorize cells by bud size during analysis.

  • Experimental Conditions: Growth media, temperature, and growth phase can alter membrane composition and endocytic dynamics. Standardize these parameters across experiments and explicitly report them to facilitate comparison.

  • Tag Interference: Different fluorescent protein tags can affect protein folding, interactions, or degradation rates. Compare results with multiple tag types or positions, and validate with antibody-based detection of untagged YAP1802 .

  • Expression Level Variations: Overexpression can lead to mislocalization or aggregation. Compare expression levels by Western blot and optimize constructs to achieve near-endogenous expression .

  • Functional Redundancy: Consider redundancy with YAP1801, which shares high homology with YAP1802 and may compensate for YAP1802 defects in some conditions . Studies in yap1801Δ backgrounds may reveal YAP1802-specific functions that are masked in wild-type cells.

  • Imaging Parameters: Exposure time, detector gain, and image processing can create apparent differences in localization. Use consistent acquisition settings and include positive controls in each experiment.

  • Resolution Limitations: Different microscopy techniques provide different levels of resolution. Super-resolution approaches may reveal localization details not visible with conventional microscopy.

To resolve contradictions, consider performing epistasis experiments with related proteins (Syp1, Ede1) to establish the hierarchy of interactions . It's also possible that both contradictory observations are correct under different conditions, revealing context-dependent regulation of YAP1802.

What methodological approaches should be used when studying the effects of YAP1802 mutations on endocytosis?

When studying the effects of YAP1802 mutations on endocytosis, researchers should employ a comprehensive methodological approach that includes:

This comprehensive approach allows researchers to connect molecular defects in YAP1802 (disrupted lipid or cargo binding) to cellular phenotypes (altered protein localization and dynamics) and ultimately to functional consequences for endocytosis and membrane trafficking.

What emerging techniques could advance our understanding of YAP1802 function?

Several cutting-edge techniques could significantly advance our understanding of YAP1802 function in endocytosis and membrane trafficking:

  • Super-Resolution Microscopy:

    • Techniques like PALM, STORM, or lattice light-sheet microscopy could visualize YAP1802 dynamics at nanoscale resolution

    • These approaches could reveal details of endocytic site formation previously unobservable with conventional microscopy

    • Multi-color super-resolution imaging could precisely map the spatial relationships between YAP1802 and other endocytic proteins

  • Proximity Labeling:

    • BioID or APEX2 fusion to YAP1802 could identify proteins in its vicinity through biotinylation

    • This would provide a comprehensive interactome beyond known partners like Snc1/2

    • Temporal control of labeling could map the changing protein landscape during endocytosis progression

  • Advanced Lipidomics:

    • Mass spectrometry-based lipidomics coupled with protein interaction studies could reveal how specific lipid species affect YAP1802 binding

    • Lipid sensors could map the distribution of different phospholipids in relation to YAP1802 localization

    • In vitro reconstitution with defined lipid compositions could determine lipid specificity and binding kinetics

  • Cryo-Electron Tomography:

    • This technique could visualize endocytic structures with molecular detail

    • It might capture YAP1802 in action within its native context, revealing structural rearrangements during endocytosis

  • Optogenetic Approaches:

    • Light-inducible protein interaction systems attached to YAP1802 could trigger its recruitment or dissociation from membranes on demand

    • This would allow precise temporal control of YAP1802 function and help establish causality in endocytic events

These advanced techniques would provide unprecedented insights into the molecular mechanisms of YAP1802 function, potentially revealing new therapeutic targets for diseases involving endocytic dysfunction.

How might studies of YAP1802 inform our understanding of human disease mechanisms?

Research on YAP1802 has broader implications for understanding human disease mechanisms, particularly those involving endocytosis and membrane trafficking dysregulation:

  • Neurological Disorders:

    • The mammalian homologs of YAP1802, AP180 and CALM (Clathrin Assembly Lymphoid Myeloid leukemia protein), have been implicated in several neurological disorders

    • CALM has been associated with Alzheimer's disease through regulation of amyloid precursor protein endocytosis

    • Studies of YAP1802's interactions with Snc1/2 provide insights into how synaptic vesicle proteins are recycled in neurons , relevant for understanding synaptic dysfunction in neurodegenerative diseases

  • Cancer Biology:

    • The polarized localization mechanisms of YAP1802 dependent on anionic phospholipids may inform our understanding of cell polarity defects in cancer progression

    • Disruption of endocytic processes is increasingly recognized as a factor in cancer cell behavior, affecting receptor signaling and cell migration

  • Developmental Disorders:

    • YAP1802's role in organizing endocytic sites at specific membrane domains parallels processes in mammalian cells where AP180/CALM organizes clathrin-mediated endocytosis at specialized membrane regions

    • Disruption of these processes is implicated in developmental disorders involving cell polarity and tissue organization

  • Methodological Insights:

    • The methodology developed to study YAP1802 point mutations (K21E, K23E, L203S) provides a template for investigating how disease-associated mutations in AP180/CALM might affect protein function

    • Yeast as a model system allows rapid screening of potential therapeutic approaches targeting AP180/CALM function

The translational potential of YAP1802 research extends beyond basic cell biology, potentially contributing to novel therapeutic strategies for endocytosis-related human diseases through improved understanding of fundamental membrane trafficking mechanisms.

What are the key methodological challenges in developing specific YAP1802 assays for research applications?

Developing specific and sensitive assays for YAP1802 research presents several methodological challenges:

  • Antibody Specificity:

    • Ensuring antibodies can distinguish between the highly similar YAP1801 and YAP1802 proteins

    • Developing antibodies that recognize specific phosphorylated or modified forms of YAP1802

    • Creating antibodies that can detect conformational changes in YAP1802 upon binding to lipids or cargo

  • Functional Redundancy:

    • Distinguishing YAP1802-specific functions from those shared with YAP1801

    • Designing assays that can work in both single mutant (yap1801Δ or yap1802Δ) and double mutant (yap1801Δ yap1802Δ) backgrounds

    • Accounting for potential compensatory mechanisms that may mask phenotypes

  • Quantitative Imaging:

    • Developing standardized protocols for measuring YAP1802 recruitment and dynamics across different laboratories

    • Creating robust image analysis pipelines that can detect subtle differences in localization or dynamics

    • Establishing appropriate controls and normalization methods for quantitative comparisons

  • In Vitro Reconstitution:

    • Purifying functional YAP1802 protein that retains native binding properties

    • Creating membrane systems that accurately mimic the lipid composition of yeast plasma membrane domains

    • Developing assays that can simultaneously measure interactions with both lipids and cargo proteins

  • Temporal Resolution:

    • Capturing the rapid dynamics of YAP1802 during endocytic events, which may occur on the timescale of seconds

    • Developing methods to synchronize endocytic events for population-level analysis

    • Creating experimental designs that can establish causality in rapidly occurring sequential events

Addressing these challenges will require interdisciplinary approaches combining advanced imaging, biochemistry, genetics, and computational analysis, but will ultimately provide more precise and informative assays for understanding YAP1802 function in membrane trafficking.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.